These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23275121)

  • 1. Acute promyelocytic leukemia with t(15;17) and two previously unreported additional cytogenetic abnormalities.
    Rashidi A; Fisher SI
    Med Oncol; 2013 Mar; 30(1):392. PubMed ID: 23275121
    [No Abstract]   [Full Text] [Related]  

  • 2. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Cervera J; Montesinos P; Hernández-Rivas JM; Calasanz MJ; Aventín A; Ferro MT; Luño E; Sánchez J; Vellenga E; Rayón C; Milone G; de la Serna J; Rivas C; González JD; Tormo M; Amutio E; González M; Brunet S; Lowenberg B; Sanz MA
    Haematologica; 2010 Mar; 95(3):424-31. PubMed ID: 19903674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Labrador J; Luño E; Vellenga E; Brunet S; González-Campos J; Chillón MC; Holowiecka A; Esteve J; Bergua J; González-Sanmiguel JD; Gil C; Tormo M; Salamero O; Manso F; Fernández I; de laSerna J; Moreno MJ; Pérez-Encinas M; Krsnik I; Ribera JM; Cervera J; Calasanz MJ; Boluda B; Sobas M; Lowenberg B; Sanz MA; Montesinos P
    Leuk Lymphoma; 2019 May; 60(5):1146-1155. PubMed ID: 30526152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
    Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraploidy with double t(15;17)(q22;q21) in acute promyelocytic leukaemia.
    Mohamed M; Dun K
    Pathology; 2013 Feb; 45(2):203-5. PubMed ID: 23250036
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17).
    Wiernik PH; Sun Z; Gundacker H; Dewald G; Slovak ML; Paietta E; Kim HT; Appelbaum FR; Cassileth PA; Tallman MS
    Med Oncol; 2012 Sep; 29(3):2095-101. PubMed ID: 22729365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case.
    Specchia G; Storlazzi CT; Cuneo A; Surace C; Mestice A; Pannunzio A; Rocchi M; Liso V
    Ann Hematol; 2001 Apr; 80(4):246-50. PubMed ID: 11401094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
    Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
    Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute promyelocytic leukemia with del(6)(p23).
    Nakase K; Wakita Y; Minamikawa K; Yamaguchi T; Shiku H
    Leuk Res; 2000 Jan; 24(1):79-81. PubMed ID: 10634650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. t(15;17) hypergranular acute promyelocytic leukemia (M3) developing into a t(3;6) M3 without t(15;17) at relapse.
    Desangles F; Vilain E; Arborio M; De Revel T; Flandrin G
    Leuk Lymphoma; 1995 Sep; 19(1-2):185-8. PubMed ID: 8574167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
    Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
    Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
    Zuberi L; Adeyinka A; Kuriakose P
    Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
    [No Abstract]   [Full Text] [Related]  

  • 14. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
    Hernández JM; Martín G; Gutiérrez NC; Cervera J; Ferro MT; Calasanz MJ; Martínez-Climent JA; Luño E; Tormo M; Rayón C; Díaz-Mediavilla J; González M; González-San Miguel JD; Pérez-Equiza K; Rivas C; Esteve J; Alvarez Mdel C; Odriozola J; Ribera JM; Sanz MA;
    Haematologica; 2001 Aug; 86(8):807-13. PubMed ID: 11522536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ring Chromosome 10 in a Case of Acute Promyelocytic Leukemia.
    Shehzad S; Nadeem M; Shan S; Shamsi TS
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):941-942. PubMed ID: 27981936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
    Lu J; Jiang H; Jiang Q; Bao L; Lu XJ; Zhang Y; Lin W; Liu YR; Huang XJ; Jiang B
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2254-7. PubMed ID: 19087672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia with complex translocation t(5;17;15)(q35;q21;q22): case report and review of the literature.
    Cho SR; Park SJ; Kim HJ; Park IJ; Choi JR; Jung HJ; Park JE
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):e326-9. PubMed ID: 21617563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia.
    Yin CC; Glassman AB; Lin P; Valbuena JR; Jones D; Luthra R; Medeiros LJ
    Am J Clin Pathol; 2005 Jun; 123(6):840-8. PubMed ID: 15899774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
    Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ
    Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.